Clinicians often face uncertainty about whether they can rely on a negative chest x-ray (CXR) to rule out pneumonia in a child, even when other clinical signs and symptoms may have raised that concern ...

The US Food and Drug Administration (FDA) has granted clearance for Roche's Elecsys pTau181 test, a blood-based biomarker ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...

In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid ...

Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...

Please provide your email address to receive an email when new articles are posted on . The negative predictive value of a biomarker that detects benign vs. malignant nodules was more than 90% in men ...